rs140708189

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000381.4(MID1):​c.75C>T​(p.Cys25Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00307 in 1,209,695 control chromosomes in the GnomAD database, including 11 homozygotes. There are 1,166 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., 82 hem., cov: 22)
Exomes 𝑓: 0.0032 ( 10 hom. 1084 hem. )

Consequence

MID1
NM_000381.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.797

Publications

0 publications found
Variant links:
Genes affected
MID1 (HGNC:7095): (midline 1) The protein encoded by this gene is a member of the tripartite motif (TRIM) family, also known as the 'RING-B box-coiled coil' (RBCC) subgroup of RING finger proteins. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This protein forms homodimers which associate with microtubules in the cytoplasm. The protein is likely involved in the formation of multiprotein structures acting as anchor points to microtubules. Mutations in this gene have been associated with the X-linked form of Opitz syndrome, which is characterized by midline abnormalities such as cleft lip, laryngeal cleft, heart defects, hypospadias, and agenesis of the corpus callosum. This gene was also the first example of a gene subject to X inactivation in human while escaping it in mouse. Alternative promoter use, alternative splicing and alternative polyadenylation result in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
MID1 Gene-Disease associations (from GenCC):
  • X-linked Opitz G/BBB syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant X-10567473-G-A is Benign according to our data. Variant chrX-10567473-G-A is described in ClinVar as Benign. ClinVar VariationId is 129612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.797 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00216 (241/111646) while in subpopulation SAS AF = 0.00384 (10/2607). AF 95% confidence interval is 0.0029. There are 1 homozygotes in GnomAd4. There are 82 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 82 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MID1NM_000381.4 linkc.75C>T p.Cys25Cys synonymous_variant Exon 2 of 10 ENST00000317552.9 NP_000372.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MID1ENST00000317552.9 linkc.75C>T p.Cys25Cys synonymous_variant Exon 2 of 10 1 NM_000381.4 ENSP00000312678.4
MID1ENST00000380782.6 linkc.75C>T p.Cys25Cys synonymous_variant Exon 2 of 10 1 ENSP00000370159.1
ENSG00000291314ENST00000706950.1 linkc.*77C>T 3_prime_UTR_variant Exon 2 of 2 ENSP00000516670.1

Frequencies

GnomAD3 genomes
AF:
0.00215
AC:
240
AN:
111593
Hom.:
1
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000457
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000377
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000283
Gnomad SAS
AF:
0.00344
Gnomad FIN
AF:
0.00482
Gnomad MID
AF:
0.00837
Gnomad NFE
AF:
0.00330
Gnomad OTH
AF:
0.00398
GnomAD2 exomes
AF:
0.00272
AC:
497
AN:
182791
AF XY:
0.00254
show subpopulations
Gnomad AFR exome
AF:
0.000532
Gnomad AMR exome
AF:
0.000547
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00619
Gnomad NFE exome
AF:
0.00378
Gnomad OTH exome
AF:
0.00288
GnomAD4 exome
AF:
0.00317
AC:
3477
AN:
1098049
Hom.:
10
Cov.:
31
AF XY:
0.00298
AC XY:
1084
AN XY:
363403
show subpopulations
African (AFR)
AF:
0.000341
AC:
9
AN:
26399
American (AMR)
AF:
0.000596
AC:
21
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19383
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.00305
AC:
165
AN:
54137
European-Finnish (FIN)
AF:
0.00639
AC:
259
AN:
40526
Middle Eastern (MID)
AF:
0.00580
AC:
24
AN:
4137
European-Non Finnish (NFE)
AF:
0.00338
AC:
2846
AN:
841963
Other (OTH)
AF:
0.00330
AC:
152
AN:
46092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
154
307
461
614
768
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00216
AC:
241
AN:
111646
Hom.:
1
Cov.:
22
AF XY:
0.00242
AC XY:
82
AN XY:
33846
show subpopulations
African (AFR)
AF:
0.000456
AC:
14
AN:
30700
American (AMR)
AF:
0.000377
AC:
4
AN:
10619
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.000284
AC:
1
AN:
3518
South Asian (SAS)
AF:
0.00384
AC:
10
AN:
2607
European-Finnish (FIN)
AF:
0.00482
AC:
29
AN:
6022
Middle Eastern (MID)
AF:
0.00917
AC:
2
AN:
218
European-Non Finnish (NFE)
AF:
0.00330
AC:
175
AN:
53099
Other (OTH)
AF:
0.00393
AC:
6
AN:
1528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00294
Hom.:
22
Bravo
AF:
0.00164
EpiCase
AF:
0.00354
EpiControl
AF:
0.00296

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 17, 2014
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 23, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
1.3
DANN
Benign
0.54
PhyloP100
-0.80
PromoterAI
-0.041
Neutral
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140708189; hg19: chrX-10535513; API